New Medicatoin Retatrutide for Weight Loss in Phase 2 Trials
Medication-assisted weight-loss is advancing rapidly, with a new medication in phase 2!
Research
Anace Said
Physician/Co-founder
6/21/2020
So, we’ve heard about tirzepatide (read here), but there’s another drug in the process of research called retatrutide. The medication works similarly to tirzepatide, but it also acts on two other hormones that control blood sugar, per this Insider article. According to the article,
“Preliminary analysis from phase 2 trials indicated people taking retatrutide with obesity (a body mass index of 30 or higher), but not diabetes, could lose up to 24% of their body weight in 48 weeks, Investors Business Daily reported. That's more weight loss at a faster rate than trial results for tirzepatide, which led to 20% reduction in body weight in 72 weeks.”
Now that’s something to be excited about! When will see the medication hit the market? At the moment, that’s unclear, but it has promising implications for medication-assisted weight loss. Should we see this medication in the future, it could be an absolute game changer, so keep your eyes peeled for more information!
